Zeynab Mirzaeidoostan, Yadola Zargar, Arash Zandi Payam,
Volume 25, Issue 1 (5-2019)
Abstract
Objectives The purpose of this study was to investigate the effectiveness of acceptance and commitment therapy on death anxiety and mental health in women with HIV in Abadan City, Iran.
Methods This study has a quasi-experimental design with pre-test and post-test and control group. A sample of 30 patients referring to Abadan Behavioral Disease Counseling Center in 2015, were randomly assigned to either experimental (n=15) or control group (n=15). The experimental group received 8 sessions of acceptance and commitment treatment in two 90-minute sessions per week. The study data were collected using Templar death anxiety scale and Goldberg general health questionnaire in 3 time points; before the intervention, immediately after the intervention, and one and a half months later as the follow-up. The obtained data were analyzed by analysis of covariance in SPSS V. 16.
Results The results of covariance analysis showed that acceptance and commitment treatment reduced death anxiety (P<0.001) and increased mental health (P<0.001) in the experimental group compared with the control group at the post-test and follow-up period.
Conclusion Acceptance and commitment therapy can be effective in reducing death anxiety and improving the mental health of patients with HIV. Therefore, acceptance and commitment treatment as a complementary therapy along with therapeutic treatments in these patients is recommended to improve the psychological symptoms.
Mehdi Ebrahimpour Azizi, Nader Hajloo, Mohammad Baghbanian,
Volume 30, Issue 1 (7-2024)
Abstract
Objectives The present study aims to investigate the effectiveness of compassion-focused acceptance and commitment therapy (CFACT) on pain self-efficacy and pain catastrophizing in patients with multiple sclerosis (MS).
Methods This is a randomized controlled clinical trial with a pre-test/post-test design. Participants were 36 patients with MS in Mazandaran province, northern Iran, in 2022-2023 who were selected by voluntary sampling method and randomly assigned to two groups: intervention (n=18) and control (n=18). The disability of patients was measured by Kretzke’s expanded disability status scale. They completed the pain self-efficacy questionnaire (PSEQ), and pain catastrophizing scale (PCS). The intervention group received the CFACT at 10 session using the protocol adapted from the book “ACT Practitioner’s Guide to the Science of Compassion”. The collected data were analyzed in SPSS v.27 using multivariate analysis of covariance
Results The CFACT increased pain self-efficacy (P=0.004) and reduced pain catastrophizing (P=0.025) in the intervention group compared to the control group at the posttest stage.
Conclusion The CFACT is effective in improving pain self-efficacy and reducing pain catastrophizing in patients with MS, by helping patients shift their focus from catastrophizing pain to engaging in meaningful activities.This treatment can be used in clinics and hospitals.
